Klotho Neurosciences Inc.

NASDAQ: KLTO
Share price (8/15/25): $0.86
Market cap (8/15/25): $27.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

Late quarterly filing notification for Q2 2025

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Late quarterly filing notification for Q3 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement

Shelf registration

Prospectus supplement

Ownership Filter

Hirschman Shalom

El-Dada Riad Hussein

Zentman Samuel M

News Filter

(KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene’s Platform Technology

Change in Directors, Officers or Compensation

Partners With AAVnerGene Inc. to Make Klotho’s Gene Therapy Assets

Regains Full Compliance With NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis

Proxies Filter

Preliminary proxy

Definitive proxy

Preliminary proxy

Proxy related to merger

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness